AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

DIMERIX LIMITED Capital/Financing Update 2007

Dec 30, 2007

64804_rns_2007-12-30_e99b3908-30b9-4ec4-88be-67eef0963158.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

==> picture [234 x 86] intentionally omitted <==

31 December 2007

Sun Biomedical Limited Section 708A - Cleansing statement

Sun Biomedical Limited (ASX:SBN) ( Sun Biomedical ) seeks to rely on section 708A(5) of the Corporations Act 2001 (Cth) and gives notice under section 708A(5)(e) of the Act of the following details:

(a) Sun Biomedical issued 21,235,000 fully paid ordinary shares ( Shares ) on 31 December to sophisticated and professional investors at an issue price of 4.3 cents per share to raise $913,105 (before costs of the issue);
(b) Sun Biomedical issued the Shares without disclosure to investors under Part 6D.2 of the Act;
(c) as at the date of this notice, Sun Biomedical has complied with:
- (i) the provisions of Chapter 2M of the Act as they apply to Sun Biomedical; and
- (ii) section 674 of the Act; and
(d) as at the date of this notice, there is no information to be disclosed that is “excluded information” within the meaning of section 708A(7) of the Act.

For further information contact:

Andrew Paice

Director

Telephone: +61 3 8610 6370 Facsimile: +61 3 8610 6374 Email: [email protected]

Sun Biomedical Limited